DELIVERING EXTRAORDINARY. EMPOWERING ORDINARY. Trademark

Trademark Overview


On Tuesday, January 9, 2018, a trademark application was filed for DELIVERING EXTRAORDINARY. EMPOWERING ORDINARY. with the United States Patent and Trademark Office. The USPTO has given the DELIVERING EXTRAORDINARY. EMPOWERING ORDINARY. trademark a serial number of 87748712. The federal status of this trademark filing is REGISTERED as of Tuesday, August 28, 2018. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The DELIVERING EXTRAORDINARY. EMPOWERING ORDINARY. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases
delivering extraordinary. empowering ordinary.

General Information


Serial Number87748712
Word MarkDELIVERING EXTRAORDINARY. EMPOWERING ORDINARY.
Filing DateTuesday, January 9, 2018
Status700 - REGISTERED
Status DateTuesday, August 28, 2018
Registration Number5549798
Registration DateTuesday, August 28, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements


Goods and ServicesPharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2018
Primary Code042
First Use Anywhere DateMonday, January 8, 2018
First Use In Commerce DateMonday, January 8, 2018

Trademark Owner History


Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Monday, August 28, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 3, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 3, 2018ASSIGNED TO LIE
Thursday, April 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 16, 2018EXAMINER'S AMENDMENT ENTERED
Monday, April 16, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 16, 2018EXAMINERS AMENDMENT E-MAILED
Monday, April 16, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, April 13, 2018ASSIGNED TO EXAMINER
Tuesday, January 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 12, 2018NEW APPLICATION ENTERED